Clinical Trial Update: Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating anticoagulation therapy in hemodialysis patients with atrial fibrillation has completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• End-stage Renal Disease

Snippet

Sponsor: Christopher Granger, MD | Conditions: Atrial Fibrillation, End Stage Renal Disease | Phase 4 | Status: COMPLETED | Results posted: 2020-12-29